Erythropoietin prevents PC12 cells from beta-amyloid-induced apoptosis via PI3K/Akt pathway

Translational Neurodegeneration

Volumn 1, Issue , 2012, Pages

  Zhi Kun, Sun ^a,b   Hong Qi, Yang ^a   Zhi Quan, Wang ^a   Jing, Pan ^a   Zhen, Hong ^a   Sheng Di, Chen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Alzheimer's disease; Apoptosis; Beta amyloid peptide; Erythropoietin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; AMYLOID BETA PROTEIN; CASPASE 3; ERYTHROPOIETIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL STRAIN; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; IN VITRO STUDY; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 84883602573     PISSN: None     EISSN: 20479158     Source Type: Journal    
DOI: 10.1186/2047-9158-1-7     Document Type: Article

References (54)

1. Yoshioka K. Molecular mechanism of neuronal cell death in Alzheimer's disease. Nippon Ronen Igakkai Zasshi 1998, 35(4):265-267.
2. Cotman CW, Anderson AJ. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 1995, 10(1):19-45.
3. Cotman CW, Su JH. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol 1996, 6(4):493-506.
4. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999, 399(6738 Suppl):A23-A31.
5. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001, 81(2):741-766.
6. Satou T, Cummings BJ, Cotman CW. Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res 1995, 697(1-2):35-43.
7. Su JH, Deng G, Cotman CW. Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. J Neuropathol Exp Neurol 1997, 56(1):86-93.
8. Lasne F, de Ceaurriz J. Recombinant erythropoietin in urine. Nature 2000, 405(6787):635.
9. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001, 412(6847):641-647.
10. Sinor AD, Greenberg DA. Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci Lett 2000, 290(3):213-215.
11. Sakanaka M, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998, 95(8):4635-4640.
12. Siren AL, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001, 98(7):4044-4049.
13. Ehrenreich H, et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 2007, 130(Pt 10):2577-2588.
14. Chung YH, et al. Age-related changes in erythropoietin immunoreactivity in the cerebral cortex and hippocampus of rats. Brain Res 2004, 1018(1):141-146.
15. Yang HQ, et al. New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing alpha-secretase activity. Eur J Neurosci 2007, 26(2):381-391.
16. Sun ZK, et al. Protective effects of erythropoietin on tau phosphorylation induced by beta-amyloid. J Neurosci Res 2008, 86(13):3018-3027.
17. Sui X, Krantz SB, Zhao ZJ. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways. Br J Haematol 2000, 110(1):63-70.
18. Myklebust JH, et al. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells. Exp Hematol 2002, 30(9):990-1000.
19. Bao H, et al. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood 1999, 93(11):3757-3773.
20. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297(5580):353-356.
21. Pereira C, et al. Cell degeneration induced by amyloid-beta peptides: implications for Alzheimer's disease. J Mol Neurosci 2004, 23(1-2):97-104.
22. Clementi ME, et al. Alzheimer's amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35. Biochem Biophys Res Commun 2006, 342(1):206-213.
23. Juul SE, et al. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 1998, 43(1):40-49.
24. Brines ML, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000, 97(19):10526-10531.
25. Martinez-Estrada OM, et al. Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 2003, 18(9):2538-2544.
26. Konishi Y, et al. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res 1993, 609(1-2):29-35.
27. Ehrenreich H, et al. Erythropoietin: novel approaches to neuroprotection in human brain disease. Metab Brain Dis 2004, 19(3-4):195-206.
28. Lewczuk P, et al. Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport 2000, 11(16):3485-3488.
29. Kubo T, Nishimura S, Oda T. Amyloid beta-peptide alters the distribution of early endosomes and inhibits phosphorylation of Akt in the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Brain Res Mol Brain Res 2002, 106(1-2):94-100.
30. Iversen LL, et al. The toxicity in vitro of beta-amyloid protein. Biochem J 1995, 311(Pt 1):1-16.
31. Pike CJ, et al. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 1995, 64(1):253-265.
32. Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 1990, 250(4978):279-282.
33. D'Ursi AM, et al. Solution structure of amyloid beta-peptide (25-35) in different media. J Med Chem 2004, 47(17):4231-4238.
34. Giunta S, et al. Transferrin neutralization of amyloid beta 25-35 cytotoxicity. Clin Chim Acta 2004, 350(1-2):129-136.
35. Misiti F, et al. Abeta(31-35) peptide induce apoptosis in PC 12 cells: contrast with Abeta(25-35) peptide and examination of underlying mechanisms. Neurochem Int 2005, 46(7):575-583.
36. Kosuge Y, et al. Comparative study of endoplasmic reticulum stress-induced neuronal death in rat cultured hippocampal and cerebellar granule neurons. Neurochem Int 2006, 49(3):285-293.
37. Cummings MC, Winterford CM, Walker NI. Apoptosis. Am J Surg Pathol 1997, 21(1):88-101.
38. Yang J, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997, 275(5303):1129-1132.
39. Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria?. Genes Cells 1998, 3(11):697-707.
40. Zhong LT, et al. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 1993, 90(10):4533-4537.
41. Wolter KG, et al. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997, 139(5):1281-1292.
42. Grutter MG. Caspases: key players in programmed cell death. Curr Opin Struct Biol 2000, 10(6):649-655.
43. Wang XJ, Xu JX. Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP + -induced cytotoxicity. Neurosci Res 2005, 51(2):129-138.
44. Lee MK, et al. Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Exp Mol Med 2007, 39(3):376-384.
45. Stadelmann C, et al. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol 1999, 155(5):1459-1466.
46. Awasthi A, Matsunaga Y, Yamada T. Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides. Exp Neurol 2005, 196(2):282-289.
47. Alvarez-Gonzalez R, et al. Selective loss of poly(ADP-ribose) and the 85-kDa fragment of poly(ADP-ribose) polymerase in nucleoli during alkylation-induced apoptosis of HeLa cells. J Biol Chem 1999, 274(45):32122-32126.
48. Lee DH, Park T, Kim HW. Induction of apoptosis by disturbing mitochondrial-membrane potential and cleaving PARP in Jurkat T cells through treatment with acetoxyscirpenol mycotoxins. Biol Pharm Bull 2006, 29(4):648-654.
49. Oliver FJ, et al. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 1998, 273(50):33533-33539.
50. Damen JE, et al. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. Embo J 1995, 14(22):5557-5568.
51. Miura O, et al. Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol Cell Biol 1991, 11(10):4895-4902.
52. Joneja B, Wojchowski DM. Mitogenic signaling and inhibition of apoptosis via the erythropoietin receptor Box-1 domain. J Biol Chem 1997, 272(17):11176-11184.
53. Sakamoto H, Kitamura T, Yoshimura A. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells. J Biol Chem 2000, 275(46):35857-35862.
54. Valk P, et al. Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2. Hematol J 2000, 1(4):254-263.